Fatty acid synthase: a new anti-tumor target

被引：6

作者：

Puig, Teresa ^{[1
,2
]}

Porta, Rut ^{[1
]}

Colomer, Ramon ^{[1
,3
]}

机构：

[1] Hosp Univ Dr Josep Trueta, Inst Invest Biomed Girona IdIBGi, Inst Catalan Oncol ICO Girona, Girona, Spain

[2] Univ Girona UdG, Fac Med, Girona, Spain

[3] Ctr Oncol MD Anderson Espana, Madrid, Spain

来源：

MEDICINA CLINICA | 2009年 / 132卷 / 09期

关键词：

Cancer; Fatty acid metabolism; Fatty acid synthase; New antitumor drugs; COA-CARBOXYLASE-ALPHA; BREAST-CANCER CELLS; PROSTATE-CANCER; GREEN TEA; THERAPEUTIC TARGET; FAS EXPRESSION; INCREASED RISK; FOOD-INTAKE; INHIBITION; ACTIVATION;

D O I：

10.1016/j.medcli.2008.07.022

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fatty acid synthase (FASN), an enzyme capable of de novo fatty acid synthesis, is highly expressed and activated in most human carcinomas. FASN is associated with poor prognosis in prostate and breast cancer and its inhibition is selectively cytotoxic to human cancer cells. Thus, FASN and fatty acid metabolism have become an important focus for the diagnostic and treatment of cancer. In this sense, there is an increasing interest in identifying and developing new antitumor compounds that inhibit FASN. (C) 2008 Elsevier Espana, S.L. All rights reserved.

引用

页码：359 / 363

页数：5

共 50 条

[31] Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
Vanauberg, Dimitri
Schulz, Celine
Lefebvre, Tony
ONCOGENESIS, 2023, 12 (01)
[32] New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
Turrado, Carlos
Puig, Teresa
Garcia-Carceles, Javier
Artola, Marta
Benhamu, Bellinda
Ortega-Gutierrez, Silvia
Relat, Joana
Oliveras, Gloria
Blancafort, Adriana
Haro, Diego
Marrero, Pedro F.
Colomer, Ramon
Lopez-Rodriguez, Maria L.
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5013 - 5023
[33] Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
Villeger, Romain
Lopes, Amelie
Carrier, Guillaume
Veziant, Julie
Billard, Elisabeth
Barnich, Nicolas
Gagniere, Johan
Vazeille, Emilie
Bonnet, Mathilde
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (18)
[34] Galbanic Acid Isolated from Ferula assafoetida Exerts In Vivo Anti-tumor Activity in Association with Anti-angiogenesis and Anti-proliferation
Kim, Kwan-Hyun
Lee, Hyo-Jung
Jeong, Soo-Jin
Lee, Hyo-Jeong
Lee, Eun-Ok
Kim, Hyun-Seok
Zhang, Yong
Ryu, Shi-Yong
Lee, Min-Ho
Lue, Junxuan
Kim, Sung-Hoon
PHARMACEUTICAL RESEARCH, 2011, 28 (03) : 597 - 609
[35] Inhibition of Coix seed extract on fatty acid synthase, a novel target for anticancer activity
Yu, Fei
Gao, Jing
Zeng, Yong
Liu, Chang-Xiao
JOURNAL OF ETHNOPHARMACOLOGY, 2008, 119 (02) : 252 - 258
[36] Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma
Walz, J. Z.
Saha, J.
Arora, A.
Khammanivong, A.
O'Sullivan, M. G.
Dickerson, E. B.
VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (01) : E99 - E108
[37] Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target
Ahmad, Nuha
Moton, Safwan
Kuttikrishnan, Shilpa
Prabhu, Kirti S.
Masoodi, Tariq
Ahmad, Sarfraz
Uddin, Shahab
PATHOLOGY RESEARCH AND PRACTICE, 2024, 260
[38] Synthesis of Ursolic Acid Analogues and Their Anti-tumor Activities
Meng, Yanqiu
Liu, Dan
Cai, Lingli
Jie, Bai
Chen, Hong
Bo, Cao
PROCEEDINGS OF 2009 INTERNATIONAL CONFERENCE OF NATURAL PRODUCT AND TRADITIONAL MEDICINE, VOLS 1 AND 2, 2009, : 594 - 598
[39] Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity
Katira, Arnav
Tan, Peng H.
EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1105 - 1125
[40] Fatty acid synthase reprograms the epigenome in uterine leiomyosarcomas
Guan, Min
Wu, Xiwei
Chu, Peiguo
Chow, Warren A.
PLOS ONE, 2017, 12 (06):

← 1 2 3 4 5 →